Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Microbiol Spectr ; 10(4): e0096422, 2022 08 31.
Article in English | MEDLINE | ID: mdl-35703554

ABSTRACT

The genus Enterobacter includes species responsible for nosocomial outbreaks in fragile patients, especially in neonatal intensive care units (NICUs). Determining the primary source of infection is critical to outbreak management and patient outcomes. In this investigation, we report the management and control measures implemented during an Enterobacter outbreak of bloodstream infections in premature babies. The study was conducted in a French NICU over a 3-year period (2016 to 2018) and included 20 premature infants with bacteremia. The clinical and microbiological characteristics were identified, and whole-genome sequencing (WGS) was performed on bacteremia isolates. Initially, several outbreak containment strategies were carried out with no success. Next, outbreak investigation pinpointed the neonatal incubators as the primary reservoir and source of contamination in this outbreak. A new sampling methodology during "on" or "in use" conditions enabled its identification, which led to their replacement, thus resulting in the containment of the outbreak. WGS analysis showed a multiclonal outbreak. Some clones were identified in different isolation sources, including patients and neonatal incubators. In addition, microbiological results showed a multispecies outbreak with a high prevalence of Enterobacter bugandensis and Enterobacter xiangfangensis. We conclude that the NICU health care environment represents an important reservoir for Enterobacter transmission and infection. Finally, extracting samples from the neonatal incubator during active use conditions improves the recovery of bacteria from contaminated equipment. This method should be used more frequently to achieve better monitoring of the NICU for HAIs prevention. IMPORTANCE Neonatal incubators in the NICU can be an important reservoir of pathogens responsible for life-threatening outbreaks in neonatal patients. Traditional disinfection with antiseptics is not sufficient to eradicate the microorganisms that can persist for long periods in the different reservoirs. Identification and elimination of the reservoirs are crucial for outbreak prevention and control. In our investigation, using a new strategy of microbiological screening of neonatal incubators, we demonstrated that these were the primary source of contamination. After their replacement, the outbreak was controlled. This new methodology was effective in containing this outbreak and could be a viable alternative for infection prevention and control in outbreak situations involving incubators as a reservoir.


Subject(s)
Bacteremia , Cross Infection , Neonatal Sepsis , Bacteremia/epidemiology , Bacteremia/prevention & control , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/prevention & control , Disease Outbreaks/prevention & control , Enterobacter/genetics , Humans , Incubators , Infant , Infant, Newborn , Neonatal Sepsis/epidemiology , Neonatal Sepsis/prevention & control
2.
Ann Biol Clin (Paris) ; 78(6): 639-646, 2020 Dec 01.
Article in French | MEDLINE | ID: mdl-33258456

ABSTRACT

Type 2 heparin-induced thrombocytopenia (HIT 2) is a rare pro-thrombotic disorder occurring in patients treated with heparin. It is defined as a clinical-biological syndrome associating the sudden onset of a thrombocytopenia, characterized by a drop of more than 50% of the initial platelet count, and thrombosis. We report two cases of HIT 2 occurring in patients with major bleeding tendency. The first HIT occurred in a patient whose management, in accordance with current guidelines, made it possible to control the thrombocytopenia and the anticoagulation despite the complexity of adapting and monitoring treatments in the context of recent cerebral hemorrhage. The second refers to an autoimmune HIT, which occurred in a patient whose management required the use of alternative therapies to the standard treatments suggested for HIT 2, to correct the severe refractory thrombocytopenia.


Subject(s)
Blood Coagulation Disorders/therapy , Hemorrhage/prevention & control , Heparin/adverse effects , Thrombocytopenia/chemically induced , Thrombocytopenia/therapy , 4-Hydroxycoumarins/administration & dosage , Aged , Anticoagulants/adverse effects , Arginine/administration & dosage , Arginine/analogs & derivatives , Blood Coagulation Disorders/complications , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Therapy, Combination , Hemorrhage/etiology , Humans , Indenes/administration & dosage , Intracranial Thrombosis/drug therapy , Intracranial Thrombosis/etiology , Intracranial Thrombosis/surgery , Male , Middle Aged , Neurosurgical Procedures/methods , Pipecolic Acids/administration & dosage , Sulfonamides/administration & dosage , Vitamin K/administration & dosage , Vitamin K/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...